Estados financieros detallados de Kalaris Therapeutics Inc (KLRS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $3.18, KLRS presenta beneficios negativos (P/E no significativo) y un ROE del -71.71%. La capitalización bursátil es de $69M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $1.1M | $165000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | $73000 | $1.1M | 0 | 0 | 0 | $13000 |
| Beneficio Bruto | 0 | 0 | -$73000 | -$1.1M | 0 | 0 | 0 | -$13000 |
| I+D | $1.7M | $16.2M | $49.6M | $119.6M | $11.8M | $11.7M | $12.3M | $30.8M |
| Generales y Administrativos | $3.0M | $10.6M | $21.6M | $49.1M | $2.2M | $1.8M | $42.9M | $15.4M |
| Gastos Operativos | $4.7M | $26.8M | $71.2M | $168.7M | $14.0M | $13.5M | $55.3M | $46.1M |
| Beneficio Operativo | -$3.6M | -$26.7M | -$71.3M | -$169.8M | -$14.0M | -$13.5M | -$55.3M | -$46.2M |
| EBITDA | -$2.4M | -$23.8M | -$69.7M | -$169.8M | -$15.2M | -$14.0M | -$58.8M | -$42.0M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | $235000 | $687000 | 0 | $1.4M |
| Beneficio Antes de Impuestos | -$2.4M | -$23.8M | -$69.8M | -$171.0M | -$15.5M | -$14.7M | -$58.8M | -$43.4M |
| Impuestos | 0 | 0 | 0 | $1.0M | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$2.4M | -$23.8M | -$69.8M | -$172.0M | -$15.5M | -$14.7M | -$58.8M | -$43.4M |
| BPA | $-2.88 | $-8.42 | $-59.67 | $-63.00 | $-50.62 | $-42.09 | $-11.73 | $-2.85 |
| BPA Diluido | $-2.88 | $-8.42 | $-59.67 | $-63.00 | $-50.62 | $-42.09 | $-11.73 | $-2.85 |
| Acciones en Circulación (Diluidas) | $2.8M | $2.8M | $1.2M | $2.7M | $3.3M | $4.5M | $5.0M | $15.3M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | -$10000 | -$10000 | 0 |
| Beneficio Operativo | -$12.7M | -$10.8M | -$11.8M | -$12.4M |
| EBITDA | -$11.9M | -$10.0M | -$10.8M | -$12.4M |
| Beneficio Neto | -$11.9M | -$10.0M | -$10.9M | -$11.5M |
| BPA | $-0.64 | $-0.44 | $-0.46 | $-0.48 |
| BPA Diluido | $-0.64 | $-0.44 | $-0.46 | $-0.48 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $25.0M | $61.1M | $122.7M | $201.7M | $3.1M | $3.2M | $118.3M | $98.1M |
| Inversiones a Corto | 0 | $65.0M | $233.7M | $46.5M | 0 | 0 | 0 | $19.9M |
| Cuentas por Cobrar | $302000 | $560000 | $450000 | $50000 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $25.3M | $127.3M | $361.3M | $253.3M | $3.9M | $3.3M | $118.5M | $118.8M |
| Inmovilizado Material | 0 | $12.1M | $9.5M | $31.3M | 0 | 0 | 0 | $1.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $25.3M | $139.4M | $370.8M | $286.6M | $3.9M | $3.3M | $118.5M | $121.7M |
| Cuentas por Pagar | $153000 | $630000 | $963000 | $8.4M | $2.8M | $2.4M | $247000 | $1.3M |
| Deuda a Corto | 0 | $3.1M | $3.2M | $6.6M | 0 | 0 | 0 | $316000 |
| Pasivos Corrientes | $3.7M | $9.1M | $12.3M | $37.9M | $5.7M | $3.9M | $5.2M | $9.7M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $3.3M | 0 | 0 | 0 |
| Pasivos Totales | $3.7M | $17.8M | $17.8M | $61.3M | $34.2M | $48.4M | $5.2M | $42.9M |
| Reservas | -$31.5M | -$55.3M | -$125.1M | -$297.1M | -$32.7M | -$47.4M | -$715.0M | -$160.0M |
| Patrimonio Neto | $21.6M | $121.6M | $353.1M | $225.3M | -$30.3M | -$45.0M | $113.3M | $78.8M |
| Deuda Total | 0 | $11.8M | $8.7M | $30.1M | $3.3M | 0 | 0 | $1.4M |
| Deuda Neta | -$25.0M | -$114.3M | -$347.6M | -$218.1M | $194000 | -$3.2M | -$118.3M | -$116.5M |
| Capital Circulante | $21.6M | $118.2M | $349.0M | $215.5M | -$1.8M | -$609000 | $113.3M | $109.1M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $42.4M | $98.1M | $34.4M | $43.2M |
| Activos Totales | $81.2M | $121.7M | $109.8M | $99.5M |
| Pasivos Totales | $39.3M | $42.9M | $41.2M | $41.9M |
| Patrimonio Neto | $41.9M | $78.8M | $68.6M | $57.7M |
| Deuda Total | $1.5M | $1.4M | $1.4M | $1.4M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$2.4M | -$23.8M | -$69.8M | -$172.0M | -$15.5M | -$14.7M | -$58.8M | -$43.4M |
| Amortizaciones | 0 | $19000 | $73000 | $1.1M | 0 | 0 | 0 | $13000 |
| Compensación en Acciones | 0 | 0 | 0 | 0 | $271000 | $148000 | 0 | 0 |
| Cambio en Capital Circulante | $3.4M | $1.4M | -$1.0M | $19.4M | $3.4M | -$1.1M | -$25.3M | $3.4M |
| Flujo de Caja Operativo | $1.9M | -$20.2M | -$60.8M | -$106.3M | -$9.8M | -$14.1M | -$67.7M | -$43.0M |
| Inversiones (CapEx) | 0 | -$339000 | -$235000 | -$26000 | 0 | 0 | 0 | -$200000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | -$10.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | $1.9M | -$20.5M | -$61.0M | -$106.3M | -$9.8M | -$14.1M | -$67.7M | -$43.2M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$11.3M | -$9.3M | -$13.3M | -$11.4M |
| Inversiones (CapEx) | -$183000 | -$17000 | 0 | 0 |
| Flujo de Caja Libre | -$11.5M | -$9.3M | -$13.3M | -$11.4M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $638000 | 0 | 0 | 0 |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -85.5% | -100.0% | | | | | |
| Crecimiento Beneficio Neto (anual) | | -881.0% | -192.7% | -146.4% | +91.0% | +5.1% | -299.8% | +26.1% |
| Crecimiento BPA (anual) | | -192.4% | -608.7% | -5.6% | +19.6% | +16.9% | +72.1% | +75.7% |
| Cambio en Acciones (anual) | | +0.0% | -58.7% | +133.4% | +22.1% | +35.7% | +10.7% | +204.8% |
| Crecimiento FCF (anual) | | -1154.8% | -197.9% | -74.2% | +90.8% | -44.5% | -379.1% | +36.2% |
| Margen Bruto | 0.0% | 0.0% | | | | | | |
| Margen Operativo | -316.8% | -16182.4% | | | | | | |
| Margen EBITDA | -214.1% | -14436.4% | | | | | | |
| Margen Neto | -214.1% | -14447.9% | | | | | | |
| Margen FCF | 171.2% | -12420.6% | | | | | | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.6% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $0.69 | $-7.24 | $-52.20 | $-38.96 | $-2.93 | $-3.12 | $-13.52 | $-2.83 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $2.8M | $2.8M | $1.2M | $2.7M | $3.3M | $4.5M | $5.0M | $15.3M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -71.71% |
| Rentabilidad sobre capital invertido | -52.40% |
| Rentabilidad sobre activos | -44.47% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 10.98 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -0.21 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -4663.65 | -1595.17 | -340.79 | -108.65 | -53.61 | -8.65 | -18.94 | -2.96 |
| P/VC | 1761.67 | 312.61 | 67.35 | 82.95 | -298.77 | -36.59 | 9.82 | 1.63 |
| P/V | 33498.20 | 230426.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | -316.8% | -16182.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | -214.1% | -14447.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |